📣 Calling all HCPs! Help us identify educational needs in Alagille syndrome (ALGS). Is this a gap in clinical practice? Discussing inherited risk, uncertainty about disease severity, and genetic testing or screening options with families affected by ALGS.

🧬 Calling all HCPs! Help us identify educational needs in Alagille syndrome (ALGS). Is this a gap in clinical practice? Determining appropriate genetic evaluation, family risk assessment, and specialist referral for relatives of patients with ALGS.

👋 Calling all HCPs! Help us identify educational needs in Alagille syndrome (ALGS). Is this a gap in clinical practice? Recognizing which relatives of patients with ALGS may need evaluation, particularly when symptoms are subtle or absent.

💡HCP perspectives wanted We’re exploring early excess adiposity care. Is the following a gap in clinical practice? Planning and monitoring long-term treatment, including managing side effects during dose escalation to support treatment continuation.

👋HCPs, we’d love to hear from you We’re exploring early excess adiposity care. Is the following a gap in clinical practice? Starting person-first weight discussions and shared decision-making when patients attend for other health concerns.

📢Calling all HCPs We’re exploring early excess adiposity care. Is the following a gap in clinical practice? Moving beyond lifestyle-only approaches to integrate timely, evidence-based pharmacotherapy when appropriate.

🏥Clinician insights wanted We’re exploring early excess adiposity care. Is the following a gap in clinical practice? Using clinical staging and accurate documentation to identify patients with BMI 27–<30 and weight-related complications.

👋 Pediatric HCPs — we’d value your perspective. Is this a gap in clinical practice? Limited confidence in recognizing signs, symptoms, and diagnostic red flags suggestive of PFIC and Alagille syndrome in infants and children.

🏥 Calling HCPs caring for people with sickle cell disease. How confident are you coordinating multidisciplinary care, clarifying team responsibilities and identifying support for barriers to access and continuity?

💊 Calling HCPs caring for people with sickle cell disease. How confident are you appraising evidence for established and emerging treatments to discuss benefits, risks and treatment burden in line with each person's goals?

🥼 Calling HCPs caring for people with sickle cell disease. How confident are you anticipating changing care needs across life stages, including self-management, reproductive goals and priorities in later adulthood?

👋 Calling HCPs caring for people with sickle cell disease. How confident are you assessing fatigue, quality of life and possible organ complications beyond acute crises, and deciding next steps?

🩺Clinician insights wanted We’re exploring weight management in knee osteoarthritis. Is the following a gap in clinical practice? Integrating evidence-based weight management into coordinated, multidisciplinary knee osteoarthritis care.

📊HCP perspectives wanted We’re exploring weight management in knee osteoarthritis. Is the following a gap in clinical practice? Confidence discussing obesity and weight management with patients in a sensitive, non-stigmatizing way.

📣Calling all HCPs We’re exploring weight management in knee osteoarthritis. Is the following a gap in clinical practice? Confidence applying evidence and guidelines to lifestyle and pharmacologic weight management in knee osteoarthritis.

👋HCPs, we want to hear from you We’re exploring weight management in knee osteoarthritis. Is the following a gap in clinical practice? Recognizing obesity as a metabolic and inflammatory driver of knee osteoarthritis.

🥼 US HCPs managing metastatic castration-resistant prostate cancer, we’d value your input. How confident are you in integrating clinical assessment, lab findings and patient-reported concerns to recognize and manage symptoms and treatment toxicities in multidisciplinary care?

📣 Calling US HCPs involved in adult inflammatory or hematologic care — we’d value your insight. Is this a gap in clinical practice? HCPs lack confidence in recognizing patterns that should prompt UBA1 testing and multidisciplinary evaluation for suspected VEXAS syndrome.

📊HCP perspectives wanted! We’re exploring HER2 expression in metastatic breast cancer. Is the following a gap in clinical practice? Inadequate multidisciplinary workflows for integrating HER2 IHC results into timely treatment decisions.

📣Calling all HCPs We’re exploring HER2 expression in metastatic breast cancer. Is the following a gap in clinical practice? Inconsistent HER2 terminology, reporting and communication between pathology and oncology teams.